PLx Pharma (PLXP) Misses Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to PLx Pharma (PLXP) Misses Q4 EPS by 2c

PLx Pharma Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update

March 11, 2022 6:50 AM EST

Momentum Building for Novel Vazalore® Liquid-Filled Aspirin Capsules

Total Net Sales of $8.2 Million in Last Five Months of 2021Net Sales of $1.6 Million in the Fourth Quarter 2021, Reflecting Timing of Trade Re-Orders Following Strong Initial Sales Distribution of VAZALORE in the Third Quarter 2021 Key Performance Measures Are Positive and Trending Higher; Company on Track and Well-Positioned to Grow Sales Substantially in... More